Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexaria Bioscience Corp

0.8450
+0.01501.81%
Post-market: 0.8090-0.0360-4.26%19:58 EDT
Volume:64.47K
Turnover:54.38K
Market Cap:16.53M
PE:-1.26
High:0.8625
Open:0.8300
Low:0.8255
Close:0.8300
52wk High:4.38
52wk Low:0.7941
Shares:19.56M
Float Shares:18.17M
Volume Ratio:0.54
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6688
EPS(LYR):-0.4680
ROE:-152.89%
ROA:-84.74%
PB:2.98
PE(LYR):-1.81

Loading ...

OverviewCompanyNewsFilings

Lexaria Bioscience Corp expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
Apr 05

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

ACCESS Newswire
·
Apr 03

Lexaria's Human GLP-1 Study #5 Begins Dosing

ACCESS Newswire
·
Apr 02

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)

ACCESS Newswire
·
Mar 18

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

ACCESS Newswire
·
Feb 27

Lexaria receives HREC approval for DehydraTECH-tirzepatide GLP-1 study arm

TIPRANKS
·
Feb 24

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

ACCESS Newswire
·
Feb 24

Lexaria Bioscience granted two new DehydraTECH patents

TIPRANKS
·
Feb 11

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

ACCESS Newswire
·
Feb 11

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Jul 14, 2025 Pre-Market
Financial Report Announcement
Apr 14, 2025
Financial Report Announcement
Jan 10, 2025
Financial Report Announcement
Nov 26, 2024
Financial Report Announcement
Jul 12, 2024

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.43
Current
-5.17
Sector Average
90.92%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.43
Maximum
-0.68
+1 STD
-1.60
Minimum
-15.58
-1 STD
-8.74
Average
-5.17

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.